U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 500

1.
Primary Bladder Neurofibroma: A Rare Case with Clinical Implications and Diagnostic Challenges
Srikanth Umakanthan, Ramadas Naik, Maryann Margaret Bukelo, Sharada Rai, Laxman Prabhu
J Clin Diagn Res. 2015 Sep; 9(9): ED05–ED06. Published online 2015 Sep 1. doi: 10.7860/JCDR/2015/14015.6447
PMCID:
PMC4606242
AbstractArticlePDF–478K
2.
Obstruction of the ureter by neurofibroma of the urinary bladder treated endoscopically
Ilona Pilosov Solomon, Ilan Klein, Yuval Friefeld, Rani Zreik, Gazi Fares, Yoram Dekel
Urol Case Rep. 2022 Jul; 43: 102090. Published online 2022 Apr 25. doi: 10.1016/j.eucr.2022.102090
PMCID:
PMC9065591
AbstractArticlePDF–1.9M
3.
Paediatric bladder neurofibroma on bilateral ureterostomy: rare case report—strategic management
Pavai Arunachalam, Sudipta Sen, Dhanashree Balaji, Cenita J Sam
BMJ Case Rep. 2021; 14(2): e238296. Published online 2021 Feb 19. doi: 10.1136/bcr-2020-238296
PMCID:
PMC7896621
AbstractArticlePDF–530K
4.
USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-κB signaling pathway
Yun Li, Chenghang Jiang, Quanqi Liu, Pengfei Zhou, Daxue Tian, Ying Zeng, Mingfeng Xiang
Aging (Albany NY) 2024 Apr 30; 16(8): 6757–6772. Published online 2024 Mar 28. doi: 10.18632/aging.205696
PMCID:
PMC11087123
AbstractArticlePDF–2.1M
5.
Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications
Yun-Zhi Lin, Wei-hui Liu, Yu-Peng Wu, Hai Cai, Qing-Shui Zheng, Yong Wei, Ning Xu, Xue-Yi Xue
Int J Immunopathol Pharmacol. 2024 Jan-Dec; 38: 03946320241240706. Published online 2024 May 7. doi: 10.1177/03946320241240706
PMCID:
PMC11080779
AbstractArticlePDF–1.5M
6.
Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancer
Ruize Qin, Xiaocheng Ma, Shi Pu, Chengquan Shen, Ding Hu, Changxue Liu, Kongjia Wang, Yonghua Wang
Investig Clin Urol. 2024 May; 65(3): 263–278. Published online 2024 Apr 1. doi: 10.4111/icu.20230300
PMCID:
PMC11076800
AbstractArticlePDF–20M
7.
Predicting bladder cancer survival with high accuracy: insights from MAPK pathway-related genes
Guangyang Cheng, Zhaokai Zhou, Shiqi Li, Shuai Yang, Yan Wang, Zhuo Ye, Chuanchuan Ren
Sci Rep. 2024; 14: 10482. Published online 2024 May 7. doi: 10.1038/s41598-024-61302-0
PMCID:
PMC11076554
AbstractArticlePDF–14M
8.
Analysis of Bladder Cancer Staging Prediction Using Deep Residual Neural Network, Radiomics, and RNA-Seq from High-Definition CT Images
Yao Zhou, Xingju Zheng, Zhucheng Sun, Bo Wang
Genet Res (Camb) 2024; 2024: 4285171. Published online 2024 Apr 30. doi: 10.1155/2024/4285171
PMCID:
PMC11074870
AbstractArticlePDF–3.3M
9.
Identification of cuproptosis-related long non-coding RNA and construction of a novel prognostic signature for bladder cancer: An observational study
Zegen Ye, Chunhua Liu, Simin Wu, Xinxin Jin, Huajian Lin, Tingting Wang, Qiuxia Zheng, Zhaofu Guo
Medicine (Baltimore) 2024 May 3; 103(18): e38005. Published online 2024 May 3. doi: 10.1097/MD.0000000000038005
PMCID:
PMC11062696
AbstractArticlePDF–2.8M
10.
Overexpressed KCNK1 regulates potassium channels affecting molecular mechanisms and biological pathways in bladder cancer
Wei Zhang, Xiao-Song Chen, Ying Wei, Xiao-Min Wang, Xian-Jin Chen, Bang-Teng Chi, Lin-Qing Huang, Rong-Quan He, Zhi-Guang Huang, Qi Li, Gang Chen, Juan He, Mei Wu
Eur J Med Res. 2024; 29: 257. Published online 2024 Apr 30. doi: 10.1186/s40001-024-01844-1
PMCID:
PMC11059691
AbstractArticlePDF–16M
11.
Genomic Profiling and Molecular Characterisation of Metastatic Urothelial Carcinoma
Gaetano Pezzicoli, Federica Ciciriello, Vittoria Musci, Silvia Minei, Antonello Biasi, Anna Ragno, Paola Cafforio, Mimma Rizzo
Medicina (Kaunas) 2024 Apr; 60(4): 585. Published online 2024 Mar 31. doi: 10.3390/medicina60040585
PMCID:
PMC11052409
AbstractArticlePDF–904K
12.
GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells
Alexandre Barbaud, Isabelle Lascombe, Adeline Péchery, Sergen Arslan, François Kleinclauss, Sylvie Fauconnet
Cells. 2024 Apr; 13(8): 708. Published online 2024 Apr 19. doi: 10.3390/cells13080708
PMCID:
PMC11049359
AbstractArticlePDF–7.2M
13.
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE
Yichen Wang, Yanyang Nan, Chunguang Ma, Xiaolin Lu, Qian Wang, Xiting Huang, Wenjing Xue, Jiajun Fan, Dianwen Ju, Dingwei Ye, Xuyao Zhang
Cell Death Dis. 2024 Apr; 15(4): 293. Published online 2024 Apr 25. doi: 10.1038/s41419-024-06665-y
PMCID:
PMC11045801
AbstractArticlePDF–5.5M
14.
Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth
Peishan Wu, Lingna Zhao, Guangqi Kong, Bo Song
Technol Cancer Res Treat. 2024; 23: 15330338241246649. Published online 2024 Apr 24. doi: 10.1177/15330338241246649
PMCID:
PMC11044785
AbstractArticlePDF–6.6M
15.
Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer
Jian Li, Zhiyong Wang, Tianen Wang
Sci Rep. 2024; 14: 9282. Published online 2024 Apr 23. doi: 10.1038/s41598-024-60068-9
PMCID:
PMC11039685
AbstractArticlePDF–6.3M
16.
Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model
Kazuki Yamanaka, Isao Hara, Hiroshi Nagai, Hideaki Miyake, Kazuo Gohji, Mark J. Micallef, Masashi Kurimoto, Soichi Arakawa, Sadao Kamidono
Cancer Immunol Immunother. 1999 Aug; 48(6): 297–302. doi: 10.1007/s002620050578
PMCID:
PMC11037181
AbstractArticlePDF–123K
17.
Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy
Marcella Reale, Romina Intorno, Raffaele Tenaglia, Claudio Feliciani, Renato C. Barbacane, Angela Santoni, Pio Conti
Cancer Immunol Immunother. 2002 Apr; 51(2): 91–98. Published online 2002 Jan 30. doi: 10.1007/s00262-001-0254-2
PMCID:
PMC11032816
AbstractArticlePDF–270K
18.
Construction of a DNA vaccine encoding Flk-1 extracellular domain and C3d fusion gene and investigation of its suppressing effect on tumor growth
Pei-he Liang, Ke-qin Zhang, Gui-lian Xu, Yan-feng Li, Luo-fu Wang, Zhi-lin Nie, Jin Ye, Gang Wu, Cheng-guo Ge, Feng-shuo Jin
Cancer Immunol Immunother. 2010 Jan; 59(1): 93–101. Published online 2009 Jun 19. doi: 10.1007/s00262-009-0727-2
PMCID:
PMC11030964
AbstractArticlePDF–486K
19.
Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy
David Coe, Shaima Begom, Caroline Addey, Matthew White, Julian Dyson, Jian-Guo Chai
Cancer Immunol Immunother. 2010 Sep; 59(9): 1367–1377. Published online 2010 May 18. doi: 10.1007/s00262-010-0866-5
PMCID:
PMC11030908
AbstractArticlePDF–764K
20.
Promoting effect of Antrodia camphorata as an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine
Chia-Hsin Huang, Chia-Che Chang, Chiu-Mei Lin, Sin-Ting Wang, Min-Tze Wu, Eric I. C. Li, Hsien-Chang Chang, Chi-Chen Lin
Cancer Immunol Immunother. 2010 Aug; 59(8): 1259–1272. Published online 2010 Apr 14. doi: 10.1007/s00262-010-0852-y
PMCID:
PMC11030179
AbstractArticlePDF–672K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center